Volume 108 Issue 3, 19 February 2013

Editorial

• HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?

  • H S Hochster

  Editorial Open Access 19 Feb 2013

  Advertisement

Top of page ⤴

Mini Review

• Cancer heterogeneity: implications for targeted therapeutics

  • R Fisher
  • L Pusztai
  • C Swanton

  Mini Review Open Access 08 Jan 2013

• Marine polyunsaturated fatty acids and cancer therapy

  • V C Vaughan
  • M-R Hassing
  • P A Lewandowski

  Mini Review Open Access 08 Jan 2013

Top of page ⤴

Clinical Study

• Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer

  • D Cunningham
  • R P W Wong
  • E Van Cutsem

  Clinical Study Open Access 08 Jan 2013

• A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma

  • M Peeters
  • A H Strickland
  • N C Tebbutt

  Clinical Study Open Access 29 Jan 2013

• Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas

  • K P Raj
  • J A Zell
  • F L Meyskens

  Clinical Study Open Access 22 Jan 2013

• Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer

  • S Lorenzen
  • C Pauligk
  • S-E Al-Batran

  Clinical Study Open Access 15 Jan 2013

• Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literature

  • D M Mistrangelo
  • M Bellò
  • M Morino

  Clinical Study Open Access 17 Jan 2013

• Men’s preferences for prostate cancer screening: a discrete choice experiment

  • E W de Bekker-Grob
  • J M Rose
  • E W Steyerberg

  Clinical Study Open Access 29 Jan 2013

• Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study

  • S Taghipour
  • D Banjevic
  • B J Harvey

  Clinical Study Open Access 15 Jan 2013

• Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

  • N Xenidis
  • M Perraki
  • V Georgoulias

  Clinical Study Open Access 17 Jan 2013

Top of page ⤴

Translational Therapeutics

• Regulation of tamoxifen sensitivity by a PAK1–EBP1 signalling pathway in breast cancer

  • A Ghosh
  • S Awasthi
  • A W Hamburger

  Translational Therapeutics Open Access 29 Jan 2013

• Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion

  • K Viola
  • S Kopf
  • M Grusch

  Translational Therapeutics Open Access 23 Oct 2012

• In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen

  • N Kretschy
  • M Teichmann
  • G Krupitza

  Translational Therapeutics Open Access 08 Jan 2013

• Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer

  • F Meng
  • G Sun
  • M A Brewer

  Translational Therapeutics Open Access 31 Jan 2013

• Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus

  • J C Boer
  • U M Domanska
  • A M E Walenkamp

  Translational Therapeutics Open Access 15 Jan 2013

Top of page ⤴

Molecular Diagnostics

• Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer

  • N Kachroo
  • T Valencia
  • V J Gnanapragasam

  Molecular Diagnostics Open Access 20 Nov 2012

• Astronomical algorithms for automated analysis of tissue protein expression in breast cancer

  • H R Ali
  • M Irwin
  • C Caldas

  Molecular Diagnostics Open Access 17 Jan 2013

• Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study

  • S Y Liao
  • W H Rodgers
  • E J Stanbridge

  Molecular Diagnostics Open Access 08 Jan 2013

• The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma

  • D J Pinato
  • F A Mauri
  • R Sharma

  Molecular Diagnostics Open Access 29 Jan 2013

• Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer

  • Y Hashida
  • M Imajoh
  • M Daibata

  Molecular Diagnostics Open Access 15 Jan 2013

• Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue

  • J H Kauppila
  • A E Mattila
  • T Salo

  Molecular Diagnostics Open Access 03 Jan 2013

• Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

  • N Takeshita
  • I Hoshino
  • H Matsubara

  Molecular Diagnostics Open Access 29 Jan 2013

• MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis

  • W Wu
  • M Takanashi
  • M Kuroda

  Molecular Diagnostics Open Access 15 Jan 2013

• Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting

  • J P Tiernan
  • S L Perry
  • T A Hughes

  Molecular Diagnostics Open Access 15 Jan 2013

• HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients

  • V Martin
  • L Landi
  • F Cappuzzo

  Molecular Diagnostics Open Access 24 Jan 2013

• Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer

  • C P H Vreuls
  • S W M Olde Damink
  • A Driessen

  Molecular Diagnostics Open Access 03 Jan 2013

Top of page ⤴

Short Communication

• Early mortality from colorectal cancer in England: a retrospective observational study of the factors associated with death in the first year after diagnosis

  • A Downing
  • A Aravani
  • E J A Morris

  Short Communication Open Access 03 Jan 2013

• Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers

  • G Lyratzopoulos
  • G A Abel
  • G P Rubin

  Short Communication Open Access 07 Feb 2013

Top of page ⤴

Epidemiology

• A comprehensive assessment of the impact of errors in the cancer registration process on 1- and 5-year relative survival estimates

  • M J Rutherford
  • H Møller
  • P C Lambert

  Epidemiology Open Access 29 Jan 2013

• Study populations for period analyses of cancer survival

  • L Jansen
  • T Hakulinen
  • H Brenner

  Epidemiology Open Access 29 Jan 2013

• Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

  • S Rohrmann
  • J Linseisen
  • T J Key

  Epidemiology Open Access 20 Nov 2012

• Use of statins and risk of glioma: a nationwide case–control study in Denmark

  • D Gaist
  • L Andersen
  • S Friis

  Epidemiology Open Access 15 Jan 2013

• The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study

  • S J Cotton
  • J Belcher
  • R D Neal

  Epidemiology Open Access 29 Jan 2013

• The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium

  • A S Felix
  • L S Cook
  • L A Brinton

  Epidemiology Open Access 24 Jan 2013

Top of page ⤴

Book Review

• Oncolytic viruses: methods and protocols

  • Kevin J Harrington

  Book Review Open Access 19 Feb 2013

Top of page ⤴

Letter to the Editor

• Benefits of screening cancer patients for distress still not demonstrated

  • J C Coyne

  Letter to the Editor Open Access 31 Jan 2013

• Reply: benefits of screening cancer patients for distress still not demonstrated

  • L E Carlson
  • A Waller
  • B D Bultz

  Letter to the Editor Open Access 31 Jan 2013

• A comment on ‘A morpho-molecular prognostic model for hepatocellular carcinoma’

  • I Halil Sahin
  • A Kaseb

  Letter to the Editor Open Access 19 Feb 2013

• Reply: A morpho-molecular prognostic model for hepatocellular carcinoma

  • S Srivastava
  • M Salto-Tellez

  Letter to the Editor Open Access 19 Feb 2013

• Comment on: ‘Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study’

  • L Costas
  • M Kogevinas
  • S de Sanjosé

  Letter to the Editor Open Access 27 Nov 2012

Top of page ⤴

Reply to Letter to the Editor

• Reply to comment on: ‘Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study’

  • D C Muller
  • L Baglietto
  • G Severi

  Reply to Letter to the Editor Open Access 27 Nov 2012

Top of page ⤴

Retraction

• Retraction Note: Aberrant methylation of SPARC in human lung cancers

  • M Suzuki
  • C Hao
  • A F Gazdar

  Retraction Open Access 19 Feb 2013

Top of page ⤴